Prospective longitudinal study of kinetics of humoral response to one, two, or three doses of SARS-CoV-2 vaccine in hematopoietic cell transplant recipients - Poll - MDSpire

Prospective longitudinal study of kinetics of humoral response to one, two, or three doses of SARS-CoV-2 vaccine in hematopoietic cell transplant recipients

  • By

  • Qamar J. Khan

  • Cory R. Bivona

  • Ben Liu

  • Maggie Nelson

  • Grace A. Martin

  • Muhammad Umair Mushtaq

  • Priyanka Sharma

  • Natalie R. Streeter

  • Marc Hoffmann

  • Gary C. Doolittle

  • Cuncong Zhong

  • Laura Mitchell

  • Kevin H. Li

  • Ziyan Y. Pessetto

  • Arnab Ghosh

  • Harsh B. Pathak

  • Jun Zhang

  • Andrew K. Godwin

  • Joseph P. McGuirk

  • April 6, 2022

  • 0 min

Share

Original Source(s)

Prospective longitudinal study of kinetics of humoral response to one, two, or three doses of SARS-CoV-2 vaccine in hematopoietic cell transplant recipients

  • by Qamar J. Khan, Cory R. Bivona, Ben Liu, Maggie Nelson, Grace A. Martin, Muhammad Umair Mushtaq, Priyanka Sharma, Natalie R. Streeter, Marc Hoffmann, Gary C. Doolittle, Cuncong Zhong, Laura Mitchell, Kevin H. Li, Ziyan Y. Pessetto, Arnab Ghosh, Harsh B. Pathak, Jun Zhang, Andrew K. Godwin, Joseph P. McGuirk

  • April 6, 2022

Related Content

The Care Continuum of Patients With Influenza in the Post–COVID-19 Era: A Position Paper

Journal of the Pediatric Infectious Diseases Society and the Journal of Infectious Diseases Collaboration: The First Fruits From a New Tree

Generalizability of anti–SARS-CoV-2 seroprevalence estimates to the Montréal pediatric population: a comparison between 2 weighting methods